Clinical Trials Directory

Trials / Completed

CompletedNCT01793272

Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males

Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males With Mild and Moderate Asthenozoospermia: Randomized Controlled Prospective Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Adam International Hospital · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effect of pentoxifylline used in preparation of semen samples that will be used for ICSI in infertile men complaining of mild and moderate asthenozoospermia (i.e. cases which does not need motility enhancement prior to ICSI) in comparison to semen samples without pentoxifylline preparation on the outcome of ICSI.

Detailed description

The primary outcome measures were the number of oocytes retrieved, the number of oocytes injected, number of oocytes fertilized, fertilization rate, number of embryos and their quality (G1: good embryos, G2: fair embryos and G3: bad embryos), number of embryos transferred (ET), number of embryo sacs, embryo implantation rate, pregnancy rate and abortion rate for all 3 groups and pregnancy rate and abortion rate for both group (I) and group (II).

Conditions

Interventions

TypeNameDescription
OTHEReffect of pentoxifylline on ICSI outcomesemen processing with pentoxifylline prior to ICSI

Timeline

Start date
2010-10-01
Primary completion
2011-04-01
Completion
2011-10-01
First posted
2013-02-15
Last updated
2013-02-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01793272. Inclusion in this directory is not an endorsement.